PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
EUR 38,24
Anzahl: 1 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 41,00
Anzahl: 1 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 42,98
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1st edition. 75 pages. 9.00x6.00x0.50 inches. In Stock.
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Editor(s): Altevogt, Bruce; Davis, Miriam; Hanson, Sarah. Num Pages: 88 pages, Illustrations. BIC Classification: MBGR1. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 0. . . 2010. 1st Edition. paperback. . . . . Books ship from the US and Ireland.
EUR 32,56
Anzahl: 1 verfügbar
In den WarenkorbZustand: NEW.
Zustand: New. Klappentextrnrn The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behav.
Sprache: Englisch
Verlag: National Academies Press Jan 2011, 2011
ISBN 10: 0309148839 ISBN 13: 9780309148832
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - 'The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.'--Publisher's description.